Your Menopause Journey

The following is a Sponsored Resource. The sponsor of this content has sole editorial control.

About Vivelle-Dot:

Vivelle-Dot: The #1 Prescribed Estrogen Therapy Patch*

Experience Vivelle-Dot As Part of Your Menopause Journey

The Vivelle-Dot ® patch delivers a consistent flow of estradiol to help control the moderate to severe hot flashes, night sweats and vaginal dryness and atrophy associated with menopause. Vivelle-Dot also reduces your risk of postmenopausal osteoporosis (thin, weak bones). If you are considering using Vivelle-Dot to only prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.

So what's so special about Vivelle-Dot?

Download an Informational Vivelle-Dot Patient Brochure

Download
  • Transdermal difference – Transdermals achieve therapeutic levels with smaller doses compared to oral therapy. This does not mean that Vivelle-Dot is safer or more effective than estrogen pills.
  • Size – Tiny, translucent and discreet – the smallest estrogen patch available.
  • Dosing – Changed twice a week unlike the daily use of pills or topicals.
  • Comfort – Designed to feel natural, to go where you go—during exercise, in the shower, in the pool.
  • Estrogen source – For women interested in the source of estrogen in their therapy, the estrogen in Vivelle-Dot (estradiol) is chemically synthesized from a plant source. This does not mean that Vivelle-Dot is safer or more effective than other hormone therapies.

The Patch Difference

Vivelle-Dot achieves effective hormone levels with smaller total doses compared to pills. That's true in part because the estrogen in Vivelle-Dot passes directly through the skin and into your bloodstream, avoiding the digestive tract and liver metabolism. This does not mean that Vivelle-Dot is safer or more effective than estrogen pills.

Return to Top

You'll Hardly Notice It

Vivelle-Dot is the smallest estrogen therapy (ET) patch available today — about the size of a postage stamp. It's so small and thin, you probably won't notice that you're wearing it. Vivelle-Dot uses a patented technology that allows it to stay on even during bathing, swimming or exercise.

Return to Top

Your Estrogen Therapy Should Suit You

One Less Thing to Think About

Sign up for By Your Side to get free e-mail reminders when it's time to change your Vivelle-Dot patch or refill your prescription.

Sign Up

Unlike daily pills and topical ET treatments, you only need to change the Vivelle-Dot patch twice a week.

  • There is a calendar printed on the inside cover of every box of Vivelle-Dot patches
  • Mark the days you want to change the patch, such as Sunday/Wednesday, and then change your patch on those same two days every week

Vivelle-Dot is available in 5 different dosage strengths so that your healthcare professional can adjust the dose to meet your specific needs.

In addition, Vivelle-Dot uses a patented technology that allows it to stick with you — even while you're bathing, swimming or exercising. And Vivelle-Dot has a low incidence of skin irritation.

Return to Top

Vivelle-Dot is available by prescription only and is covered with a low copay by most healthcare plans. For more information, talk to your doctor.

Risks of Estrogen Therapy

Summary of Frequently Reported Side Effects Versus Placebo in a Clinical Study

Vivelle* 0.05 mg/day

Study Population = 103 patients

  • Headache: 31.1%
  • Breast Pain: 7.8%
  • Back Pain: 8.7%

Placebo

Study Population = 157 Patients

  • Headache: 23.6%
  • Breast Pain: 0%
  • Back Pain: 6.4%

* Vivelle and Vivelle-Dot are bioequivalent (work the same way). For more information, please see Full Prescribing Information.

All estrogen therapies carry risk. Estrogens increase the chances of getting cancer of the uterus (womb). You should report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Do not use estrogens (with or without progestins) to prevent heart disease, heart attacks or strokes. Using estrogens (with or without progestins) may increase your chances of getting heart attacks, strokes, breast cancer and blood clots. Using estrogens may increase your risk of dementia (decline in memory and thinking skills).

Estrogen therapy should not be used if you:

  • Have unusual vaginal bleeding
  • Currently have or have had certain cancers, including cancer of the breast or uterus
  • Had a stroke or heart attack in the recent past (for example, in the past year)
  • Currently have or have had blood clots
  • Currently have or have had liver problems
  • May be pregnant

Common side effects of estrogen therapy include headache, breast pain, irregular vaginal bleeding, stomach cramps, bloating, nausea, vomiting and hair loss.

Before deciding if estrogen therapy is right for you, it's important to have a thorough discussion with your doctor about the individual risks and benefits of estrogen therapy. Dose and length of therapy will be based on your individual health risks and treatment goals.

Return to Top

*IMS Health®, National Prescription Audit Plus™, July 2009

Next Article:

Indication

Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.

Important Safety Information

Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).

Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.

You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.

Click here for the Full Prescribing Information for Vivelle-Dot.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

The information contained within this Web site is appropriate for U.S. residents only. A visit to this site should not replace a visit to your doctor.

Available by prescription only.

Do you experience hot flashes associated with menopause?